<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font25 { font-size : 25; } .font27 { font-size : 27; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">virus </span>
   <span class="font27">WNV </span>
   <span class="font25">West </span>
   <span class="font25">Nile </span>
   <span class="font20">flaviviruses </span>
   <span class="font18">A., </span>
   <span class="font18">M., </span>
   <span class="font18">S., </span>
   <span class="font17">flavivirus </span>
   <span class="font16">J., </span>
   <span class="font16">encephalitis </span>
   <span class="font16">Europe </span>
   <span class="font16">antibodies </span>
   <span class="font15">Dis. </span>
   <span class="font15">strain </span>
   <span class="font15">serological </span>
   <span class="font15">infections </span>
   <span class="font15">E., </span>
   <span class="font15">virus, </span>
   <span class="font14">T., </span>
   <span class="font14">N., </span>
   <span class="font14">vaccine </span>
   <span class="font14">C., </span>
   <span class="font14">JEV </span>
   <span class="font14">vaccination </span>
   <span class="font14">G., </span>
   <span class="font14">H., </span>
   <span class="font14">R., </span>
   <span class="font14">infection </span>
   <span class="font14">Virol. </span>
   <span class="font13">F., </span>
   <span class="font13">vaccines </span>
   <span class="font13">Infect. </span>
   <span class="font13">P., </span>
   <span class="font13">protection </span>
   <span class="font13">virulent </span>
   <span class="font13">B., </span>
   <span class="font13">Japanese </span>
   <span class="font13">tick-borne </span>
   <span class="font13">viruses </span>
   <span class="font12">human </span>
   <span class="font12">tests </span>
   <span class="font12">using </span>
   <span class="font12">Emerg. </span>
   <span class="font12">Vet. </span>
   <span class="font12">birds </span>
   <span class="font12">clinical </span>
   <span class="font12">humans </span>
   <span class="font12">Microbiol. </span>
   <span class="font12">species </span>
   <span class="font12">surveillance </span>
   <span class="font12">used </span>
   <span class="font12">Europe, </span>
   <span class="font12">K., </span>
   <span class="font12">European </span>
   <span class="font12">I., </span>
   <span class="font12">L., </span>
   <span class="font12">Zoonotic </span>
   <span class="font12">diagnosis </span>
   <span class="font12">diagnostic </span>
   <span class="font12">horses </span>
   <span class="font12">wild </span>
   <span class="font12">D., </span>
   <span class="font12">V., </span>
   <span class="font12">neutralizing </span>
   <span class="font12">results </span>
   <span class="font12">Med. </span>
   <span class="font12">North </span>
   <span class="font12">TBEV </span>
   <span class="font12">[./eid.] </span>
   <span class="font12">different </span>
   <span class="font12">ELISAs </span>
   <span class="font12">Nowotny </span>
   <span class="font12">Usutu </span>
   <span class="font12">Vector-Borne </span>
   <span class="font12">cases </span>
   <span class="font12">control </span>
   <span class="font12">deaths </span>
   <span class="font12">inactivated </span>
   <span class="font11">[./vbz..] </span>
   <span class="font11">bird </span>
   <span class="font11">dengue </span>
   <span class="font11">lineage </span>
   <span class="font11">specificity </span>
   <span class="font11">strains </span>
   <span class="font11">Clin. </span>
   <span class="font11">YFV </span>
   <span class="font11">antibody </span>
   <span class="font11">caused </span>
   <span class="font11">circulation </span>
   <span class="font11">infected </span>
   <span class="font11">sera </span>
   <span class="font11">vaccinated </span>
   <span class="font11">vs. </span>
   <span class="font11">Vaccine </span>
   <span class="font11">Z., </span>
   <span class="font11">animals </span>
   <span class="font11">cross-reactivity </span>
   <span class="font11">disease </span>
   <span class="font11">heterologous </span>
   <span class="font11">mosquitoes </span>
   <span class="font11">neutralization </span>
   <span class="font11">protein </span>
   <span class="font11">use </span>
   <span class="font11">Bakonyi </span>
   <span class="font11">central </span>
   <span class="font11">diversity </span>
   <span class="font11">flaviviruses, </span>
   <span class="font11">high </span>
   <span class="font11">level </span>
   <span class="font11">related </span>
   <span class="font11">study </span>
   <span class="font11">America </span>
   <span class="font11">ELISA </span>
   <span class="font11">Figure </span>
   <span class="font11">However, </span>
   <span class="font11">IgG </span>
   <span class="font11">Italy </span>
   <span class="font11">M.S., </span>
   <span class="font11">R.A., </span>
   <span class="font11">Spain </span>
   <span class="font11">Virus </span>
   <span class="font11">based </span>
   <span class="font11">new </span>
   <span class="font11">observed </span>
   <span class="font11">recombinant </span>
   <span class="font11">studies </span>
   <span class="font11">A.M., </span>
   <span class="font11">ADE </span>
   <span class="font11">American </span>
   <span class="font11">Flaviviruses </span>
   <span class="font11">SLEV </span>
   <span class="font11">Serological </span>
   <span class="font11">WNV, </span>
   <span class="font11">Y., </span>
   <span class="font11">animal </span>
   <span class="font11">assays </span>
   <span class="font11">associated </span>
   <span class="font11">available </span>
   <span class="font11">cells </span>
   <span class="font11">cross-reactions </span>
   <span class="font11">development </span>
   <span class="font11">epidemiological </span>
   <span class="font11">fever </span>
   <span class="font11">highly </span>
   <span class="font11">mosquito-borne </span>
   <span class="font11">partial </span>
   <span class="font11">patients </span>
   <span class="font11">result </span>
   <span class="font11">risk </span>
   <span class="font11">samples </span>
   <span class="font11">specific </span>
   <span class="font11">test </span>
   <span class="font11">Available </span>
   <span class="font11">B.J., </span>
   <span class="font11">Bowen </span>
   <span class="font11">Diamond </span>
   <span class="font11">E.A., </span>
   <span class="font11">Euro. </span>
   <span class="font11">Europe. </span>
   <span class="font11">Flavivirus </span>
   <span class="font11">Gen. </span>
   <span class="font11">Hubalek </span>
   <span class="font11">Hyg. </span>
   <span class="font11">JEV, </span>
   <span class="font11">Lecollinet </span>
   <span class="font11">M.A., </span>
   <span class="font11">Surveill. </span>
   <span class="font11">VNTs </span>
   <span class="font11">Weissenbock </span>
   <span class="font11">[./j.vetmic...] </span>
   <span class="font11">acute </span>
   <span class="font11">areas </span>
   <span class="font11">cross-protection </span>
   <span class="font11">cross-reactive </span>
   <span class="font11">envelope </span>
   <span class="font11">exposure </span>
   <span class="font11">flaviviruses. </span>
   <span class="font11">immunity </span>
   <span class="font11">outbreak </span>
   <span class="font11">previously </span>
   <span class="font11">recently </span>
   <span class="font11">shown </span>
   <span class="font11">vectors </span>
   <span class="font10">... </span>
   <span class="font10">Barrett </span>
   <span class="font10">DENV </span>
   <span class="font10">DNA </span>
   <span class="font10">Fever </span>
   <span class="font10">Gould </span>
   <span class="font10">IgM </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Inactivated </span>
   <span class="font10">Jourdain </span>
   <span class="font10">New </span>
   <span class="font10">Res. </span>
   <span class="font10">Rev. </span>
   <span class="font10">U., </span>
   <span class="font10">USUV </span>
   <span class="font10">Zeller </span>
   <span class="font10">[./JVI.-] </span>
   <span class="font10">[./j.vaccine...] </span>
   <span class="font10">challenge </span>
   <span class="font10">circulating </span>
   <span class="font10">considered </span>
   <span class="font10">detect </span>
   <span class="font10">detection </span>
   <span class="font10">differentiate </span>
   <span class="font10">emergence </span>
   <span class="font10">emerging </span>
   <span class="font10">epitopes </span>
   <span class="font10">hosts </span>
   <span class="font10">humans, </span>
   <span class="font10">including </span>
   <span class="font10">mice </span>
   <span class="font10">outbreaks </span>
   <span class="font10">serocomplex </span>
   <span class="font10">southern </span>
   <span class="font10">suggested </span>
   <span class="font10">tools </span>
   <span class="font10">transmission </span>
   <span class="font10">Am. </span>
   <span class="font10">Chang </span>
   <span class="font10">Culex </span>
   <span class="font10">Evaluation </span>
   <span class="font10">France </span>
   <span class="font10">J.M., </span>
   <span class="font10">J.S., </span>
   <span class="font10">M.R., </span>
   <span class="font10">Niedrig </span>
   <span class="font10">Surveillance </span>
   <span class="font10">Table </span>
   <span class="font10">Trop. </span>
   <span class="font10">[./S] </span>
   <span class="font10">absence </span>
   <span class="font10">assay </span>
   <span class="font10">belonging </span>
   <span class="font10">cell </span>
   <span class="font10">circulate </span>
   <span class="font10">closely </span>
   <span class="font10">countries </span>
   <span class="font10">cross-neutralization </span>
   <span class="font10">currently </span>
   <span class="font10">death </span>
   <span class="font10">described </span>
   <span class="font10">differ </span>
   <span class="font10">enhancement </span>
   <span class="font10">enzyme-linked </span>
   <span class="font10">evidence </span>
   <span class="font10">experimental </span>
   <span class="font10">exposed </span>
   <span class="font10">factors </span>
   <span class="font10">field </span>
   <span class="font10">group </span>
   <span class="font10">group). </span>
   <span class="font10">identified </span>
   <span class="font10">immunization </span>
   <span class="font10">immunosorbent </span>
   <span class="font10">important </span>
   <span class="font10">indirect </span>
   <span class="font10">likely </span>
   <span class="font10">mainly </span>
   <span class="font10">obtained </span>
   <span class="font10">occurred </span>
   <span class="font10">prM-E </span>
   <span class="font10">prior </span>
   <span class="font10">screening </span>
   <span class="font10">serum </span>
   <span class="font10">spread </span>
   <span class="font10">strongly </span>
   <span class="font10">target </span>
   <span class="font10">titers </span>
   <span class="font10">transmitted </span>
   <span class="font10">virus: </span>
   <span class="font10">wide </span>
   <span class="font10">A.D.T., </span>
   <span class="font10">Austria </span>
   <span class="font10">Complete </span>
   <span class="font10">Control </span>
   <span class="font10">Corvus </span>
   <span class="font10">D.H., </span>
   <span class="font10">D.J., </span>
   <span class="font10">DIII </span>
   <span class="font10">Disease </span>
   <span class="font10">Emergence </span>
   <span class="font10">Figuerola </span>
   <span class="font10">France, </span>
   <span class="font10">G.-J.J., </span>
   <span class="font10">HITs </span>
   <span class="font10">Health </span>
   <span class="font10">IFAs </span>
   <span class="font10">J.T., </span>
   <span class="font10">Jimenez-Clavero </span>
   <span class="font10">Kilpatrick </span>
   <span class="font10">Komar </span>
   <span class="font10">Murray </span>
   <span class="font10">Pierson </span>
   <span class="font10">Recent </span>
   <span class="font10">Russia </span>
   <span class="font10">S.A., </span>
   <span class="font10">Sci. </span>
   <span class="font10">T.C., </span>
   <span class="font10">TBEV, </span>
   <span class="font10">U.S. </span>
   <span class="font10">Use </span>
   <span class="font10">Vazquez </span>
   <span class="font10">YFV, </span>
   <span class="font10">Zientara </span>
   <span class="font10">ability </span>
   <span class="font10">adapted </span>
   <span class="font10">antibodies. </span>
   <span class="font10">antigenic </span>
   <span class="font10">appropriate </span>
   <span class="font10">area </span>
   <span class="font10">avian </span>
   <span class="font10">canarypox </span>
   <span class="font10">case </span>
   <span class="font10">cause </span>
   <span class="font10">commonly </span>
   <span class="font10">comparative </span>
   <span class="font10">complete </span>
   <span class="font10">complex </span>
   <span class="font10">contrast, </span>
   <span class="font10">developed </span>
   <span class="font10">diverse </span>
   <span class="font10">domestic </span>
   <span class="font10">essential </span>
   <span class="font10">facilitate </span>
   <span class="font10">frequently </span>
   <span class="font10">fusion </span>
   <span class="font10">future </span>
   <span class="font10">geographical </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">group) </span>
   <span class="font10">history </span>
   <span class="font10">however, </span>
   <span class="font10">identify </span>
   <span class="font10">individuals </span>
   <span class="font10">instance, </span>
   <span class="font10">introduced </span>
   <span class="font10">involved </span>
   <span class="font10">known </span>
   <span class="font10">limited </span>
   <span class="font10">live-attenuated </span>
   <span class="font10">models </span>
   <span class="font10">numbers </span>
   <span class="font10">occurs </span>
   <span class="font10">potential </span>
   <span class="font10">potentially </span>
   <span class="font10">present </span>
   <span class="font10">primary </span>
   <span class="font10">proteins </span>
   <span class="font10">provides </span>
   <span class="font10">range </span>
   <span class="font10">recent </span>
   <span class="font10">reported </span>
   <span class="font10">require </span>
   <span class="font10">reservoir </span>
   <span class="font10">severe </span>
   <span class="font10">structural </span>
   <span class="font10">subsequent </span>
   <span class="font10">tested </span>
   <span class="font10">ticks </span>
   <span class="font10">viremia </span>
   <span class="font10">west </span>
   <span class="font10">®—licensed </span>
   <span class="font10">(/), </span>
   <span class="font10">A.C., </span>
   <span class="font10">A.J., </span>
   <span class="font10">A.R., </span>
   <span class="font10">Africa </span>
   <span class="font10">Blitvich </span>
   <span class="font10">California </span>
   <span class="font10">Czech </span>
   <span class="font10">DII, </span>
   <span class="font10">Detection </span>
   <span class="font10">Durand </span>
   <span class="font10">ELISAs, </span>
   <span class="font10">F.X., </span>
   <span class="font10">Ferenczi </span>
   <span class="font10">Flaviviridae </span>
   <span class="font10">Fremont </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Gauthier-Clerc </span>
   <span class="font10">Greece, </span>
   <span class="font10">Hamsters </span>
   <span class="font10">Heinz </span>
   <span class="font10">Hungary </span>
   <span class="font10">IgMs </span>
   <span class="font10">Israel </span>
   <span class="font10">Johnson </span>
   <span class="font10">K.M., </span>
   <span class="font10">Leblond </span>
   <span class="font10">Louis </span>
   <span class="font10">Lussy </span>
   <span class="font10">M.J., </span>
   <span class="font10">Miller </span>
   <span class="font10">Molecular </span>
   <span class="font10">N.M., </span>
   <span class="font10">Nemeth </span>
   <span class="font10">O., </span>
   <span class="font10">P.N., </span>
   <span class="font10">PRNT </span>
   <span class="font10">Partial </span>
   <span class="font10">Porterfield </span>
   <span class="font10">Public </span>
   <span class="font10">Roehrig </span>
   <span class="font10">Rudolf </span>
   <span class="font10">S.L., </span>
   <span class="font10">Section </span>
   <span class="font10">Soriguer </span>
   <span class="font10">Spain, </span>
   <span class="font10">Sterilizing </span>
   <span class="font10">T.P., </span>
   <span class="font10">Tests </span>
   <span class="font10">Tick-borne </span>
   <span class="font10">Turdus </span>
   <span class="font10">United </span>
   <span class="font10">Vaccination </span>
   <span class="font10">WNV-specific </span>
   <span class="font10">[./S-()-] </span>
   <span class="font10">[./vir..-] </span>
   <span class="font10">address </span>
   <span class="font10">adjuvant </span>
   <span class="font10">afforded </span>
   <span class="font10">age </span>
   <span class="font10">antibodies, </span>
   <span class="font10">blackbirds </span>
   <span class="font10">called </span>
   <span class="font10">cells, </span>
   <span class="font10">co-circulation </span>
   <span class="font10">competitive </span>
   <span class="font10">confirmed </span>
   <span class="font10">cross-protective </span>
   <span class="font10">crows </span>
   <span class="font10">days </span>
   <span class="font10">detected </span>
   <span class="font10">detecting </span>
   <span class="font10">diseases </span>
   <span class="font10">distribution </span>
   <span class="font10">does </span>
   <span class="font10">domain </span>
   <span class="font10">effective </span>
   <span class="font10">encephalitic </span>
   <span class="font10">evolution </span>
   <span class="font10">false </span>
   <span class="font10">finches </span>
   <span class="font10">genetic </span>
   <span class="font10">health </span>
   <span class="font10">help </span>
   <span class="font10">hemorrhagic </span>
   <span class="font10">higher </span>
   <span class="font10">host </span>
   <span class="font10">immunity: </span>
   <span class="font10">immunoassays </span>
   <span class="font10">importance </span>
   <span class="font10">improved </span>
   <span class="font10">infection, </span>
   <span class="font10">infectious </span>
   <span class="font10">interpreting </span>
   <span class="font10">introduction </span>
   <span class="font10">isolated </span>
   <span class="font10">lead </span>
   <span class="font10">levels </span>
   <span class="font10">loop </span>
   <span class="font10">lower </span>
   <span class="font10">macaques </span>
   <span class="font10">major </span>
   <span class="font10">methods </span>
   <span class="font10">molecular </span>
   <span class="font10">monoclonal </span>
   <span class="font10">multiple </span>
   <span class="font10">nile </span>
   <span class="font10">northern </span>
   <span class="font10">particularly </span>
   <span class="font10">pathogenic </span>
   <span class="font10">patient </span>
   <span class="font10">phase </span>
   <span class="font10">pipiens </span>
   <span class="font10">presence </span>
   <span class="font10">protect </span>
   <span class="font10">protective </span>
   <span class="font10">provide </span>
   <span class="font10">regions </span>
   <span class="font10">responses </span>
   <span class="font10">responsible </span>
   <span class="font10">sample </span>
   <span class="font10">sensitive </span>
   <span class="font10">sentinel </span>
   <span class="font10">seroprevalence </span>
   <span class="font10">single </span>
   <span class="font10">sites </span>
   <span class="font10">situation </span>
   <span class="font10">susceptible </span>
   <span class="font10">systems </span>
   <span class="font10">time </span>
   <span class="font10">van </span>
   <span class="font10">veterinary </span>
   <span class="font10">viral </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses, </span>
   <span class="font10">vitro </span>
   <span class="font10">widespread </span>
   <span class="font10">yellow </span>
  </p>
 </body>
</html>
